Who has invested in Compass Therapeutics?

Montrose Capital are named among the investors backing Compass Therapeutics.

Compass Therapeutics Funding: $61M Raised, Series B (2020)

Compass Therapeutics funding overview

Compass Therapeutics is based in Boston. Compass Therapeutics has raised $61M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2020. The round record for Compass Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Montrose Capital.

Compass Therapeutics at a glance

Total raised: $61M
Latest round: Series B
Latest round date: June 2020
Headquarters: Boston
Notable investors: Montrose Capital

Frequently asked about Compass Therapeutics funding

How much has Compass Therapeutics raised?: Compass Therapeutics has raised $61M in total disclosed funding across the rounds on record.
Who has invested in Compass Therapeutics?: Montrose Capital are named among the investors backing Compass Therapeutics.
What was the latest Compass Therapeutics funding round?: The most recent disclosed round is a Series B, announced in June 2020.
Where is Compass Therapeutics based?: Compass Therapeutics is based in Boston.
When did Compass Therapeutics last raise?: The last disclosed Compass Therapeutics round closed in June 2020 at Series B.

Round data for Compass Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.

Compass Therapeutics Funding: $61M Raised, Series B (2020)

Compass Therapeutics funding overview

Compass Therapeutics at a glance

Frequently asked about Compass Therapeutics funding

Companies related to Compass Therapeutics (19)

Browse related funding lists (5)